Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydronidone in Chronic Hepatitis B-Related Liver Fibrosis
NCT07417553Phase 2Completed
- Sponsor
- Gyre Pharmaceuticals
- Start
- Apr 2026
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydronidone in Liver Fibrosis (LF), sponsored by Gyre Pharmaceuticals. Started Apr 2026; status: completed.
02
Drugs
hydronidone
03
Conditions
Liver Fibrosis (LF)
Beyond the preview
Go deeper on NCT07417553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07417553.